Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284(19):2476–82.
BMA End-of-Life Care and Physician-Assisted Dying Steering Group: End-of-life care and physician-assisted dying. 3 Reflections and recommendations, https://www.bma.org.uk/endoflifecare. Accessed 17 November 2018.
Boström B, Sandh M, Lundberg D, Fridlund B. Cancer-related pain in palliative care: patients’ perceptions of pain management. J Adv Nurs. 2004;45(4):410–9.
Kaasa S, Loge JH. Quality of life in palliative care: principles and practice. Palliat Med. 2003;17(1):11–20.
Von Gunten CF. Interventions to manage symptoms at the end of life. J Palliat Med. 2005;8(Suppl 1):s88–94.
Yang GM, Ewing G, Booth S. What is the role of specialist palliative care in an acute hospital setting? A qualitative study exploring views of patients and carers. Palliat Med. 2012;26(8):1011–7.
Barbera L, Taylor C, Dudgeon D. Why do patients with cancer visit the emergency department near the end of life? Can Med Assoc J. 2010;182(6):563–8.
Gonzales MJ, Pantilat SZ. Pain at the end of life. Hosp Med Clin. 2012;1(1):e109–23.
Johnson CE, Girgis A, Paul CL, Currow DC. Cancer specialists’ palliative care referral practices and perceptions: results of a national survey. Palliat Med. 2008;22(1):51–7.
Higginson IJ, Finlay IG, Goodwin DM, Hood K, Edwards AG, Cook A, et al. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? J Pain Symptom Manag. 2003;25(2):150–68.
Van den Beuken-van Everdingen MHJ, De Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patin J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–49.
Spiegel D, Sands S, Koopman C. Pain and depression in patients with cancer. Cancer. 1994;74(9):2570–8.
Delgado-Guay M, Parsons HA, Li Z, Palmer JL, Bruera E. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer. 2009;17(5):573–9.
Laird BJA, Scott AC, Colvin LA, McKeon AL, Murray GD, Fearon KC, et al. Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manag. 2011;42(1):1–11.
Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manag. 2006;31(1):58–69.
Murtagh FEM, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.
Zambroski CH, Moser DK, Bhat G, Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198–206.
Radbruch L, Sabatowski R, Loick G, Jonen-Thielemann I, Kasper M, Gondek B, et al. Cognitive impairment and its influence on pain and symptom assessment in a palliative care unit: development of a minimal documentation system. Palliat Med. 2000;14(4):266–76.
Dubé CE, Mack DS, Hunnicutt JN, Lapane KL. Cognitive impairment and pain among nursing home residents with cancer. J Pain Symptom Manag. 2018;55(6):1509–18.
Seow H, O’Leary E, Perez R, Tanuseputro P. Access to palliative care by disease trajectory: a population-based cohort of Ontario decedents. BMJ Open. 2018;8(4):e021147.
Smith AK, Cenzer IS, Knight SJ, Puntillo KA, Widera E, Williams BA, et al. The epidemiology of pain during the last 2 years of life. Ann Intern Med. 2010;153(9):563–9.
Home Care (HC) – interRAI, http://www.interrai.org/home-care.html. Accessed 17 November 2018.
Describing Outcome Scales (RAI-MDS 2.0). Canadian Institute for Health Information, https://www.cihi.ca/en/outcome_rai-mds_2.0_en.pdf. Accessed 17 November 2018.
Muggah E, Graves E, Bennett C, Manuel DG. The impact of multiple chronic diseases on ambulatory care use; a population based study in Ontario, Canada. BMC Health Serv Res. 2012;12:452.
Thavorn K, Maxwell CJ, Gruneir A, Bronskill SE, Bai Y, Pefoyo AJK, et al. Effect of socio-demographic factors on the association between multimorbidity and healthcare costs: a population-based, retrospective cohort study. BMJ Open. 2017;7(10):e017264.
Mondor L, Maxwell CJ, Hogan DB, Bronskill SE, Gruneir A, Lane NE, et al. Multimorbidity and healthcare utilization among home care clients with dementia in Ontario, Canada: a retrospective analysis of a population-based cohort. PLoS Med. 2017;14(3):e1002249.
Petrosyan Y, Bai YQ, Pefoyo AJK, Gruneir A, Thavorn K, Maxwell CJ, et al. The relationship between diabetes care quality and diabetes-related hospitalizations and the modifying role of comorbidity. Can J Diabetes. 2017;41(1):17–25.
Mondor L, Maxwell CJ, Bronskill SE, Gruneir A, Wodchis WP. The relative impact of chronic conditions and multimorbidity on health-related quality of life in Ontario long-stay home care clients. Qual Life Res. 2016;25(10):2619–32.
Lane NE, Maxwell CJ, Gruneir A, Bronskill SE, Wodchis WP. Absence of a socioeconomic gradient in older adults’ survival with multiple chronic conditions. EBioMedicine. 2015;2(12):2094–100.
Gruneir A, Bronskill SE, Maxwell CJ, Bai YQ, Kone AJ, Thavorn K, et al. The association between multimorbidity and hospitalization is modified by individual demographics and physician continuity of care: a retrospective cohort study. BMC Health Serv Res. 2016;16:154.
Pefoyo AJK, Bronskill SE, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, et al. The increasing burden and complexity of multimorbidity. BMC Public Health. 2015;15:415.
Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–92.
Vital Statistics - Death Database (CVSD). Statistics Canada, http://www23.statcan.gc.ca/imdb/p2SV.pl? Function=getSurvey&SDDS=5047 (2011, accessed 19 March 2020).
Fassbender K, Fainsinger RL, Carson M, Finegan BA. Cost trajectories at the end of life: the Canadian experience. J Pain Symptom Manag. 2009;38(1):75–80.
Tanuseputro P, Beach S, Chalifoux M, Wodchis WP, Hsu AT, Seow H, et al. Associations between physician home visits for the dying and place of death: a population-based retrospective cohort study. PLoS One. 2018;13(2):e0191322.
Fries BE, Simon SE, Morris JN, Flodstrom C, Bookstein FL. Pain in U.S. nursing homes: validating a pain scale for the minimum data set. Gerontologist. 2001;41(2):173–9.
Wang XS, Cleeland CS, Mendoza TR, Engstrom MC, Liu S, Xu G, et al. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer Interdiscip Int J Am Cancer Soc. 1999;86(9):1848–55.
Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277–84.
Morris JN, Fries BE, Mehr DR, Hawes C, Phillips C, Mor V, et al. MDS cognitive performance scale©. J Gerontol. 1994;49(4):M174–82.
Åbom B, Kragstrup J, Vondeling H, Bakketeig LS, Stovring H. Defining cancer patients as being in the terminal phase: who receives a formal diagnosis, and what are the effects? J Clin Oncol. 2005;23(30):7411–6.
Tanuseputro P, Budhwani S, Bai YQ, Wodchis WP. Palliative care delivery across health sectors: a population-level observational study. Palliat Med. 2017;31(3):247–57.